SMI
|
12 475,49
|
-71,28
|
-0,57%
|
Analysen zu SMI-Werten
| 04.02.25 | Roche Sell | Deutsche Bank AG | |
| 04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 04.02.25 | UBS Hold | Deutsche Bank AG | |
| 04.02.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 04.02.25 | Novartis Buy | Deutsche Bank AG | |
| 04.02.25 | UBS Outperform | RBC Capital Markets | |
| 04.02.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 03.02.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.02.25 | Novartis Hold | Deutsche Bank AG | |
| 03.02.25 | Novartis Kaufen | DZ BANK | |
| 03.02.25 | Nestlé Neutral | UBS AG | |
| 03.02.25 | Novartis Buy | UBS AG | |
| 31.01.25 | Roche Sell | Deutsche Bank AG | |
| 31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.01.25 | Novartis Buy | UBS AG | |
| 31.01.25 | ABB Sell | Deutsche Bank AG | |
| 31.01.25 | Roche Neutral | UBS AG | |
| 31.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 31.01.25 | Novartis Outperform | Bernstein Research | |
| 31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
| 31.01.25 | ABB Neutral | UBS AG | |
| 30.01.25 | Roche Outperform | Bernstein Research | |
| 30.01.25 | ABB Underperform | Bernstein Research | |
| 30.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | ABB Neutral | UBS AG | |
| 30.01.25 | Roche Neutral | UBS AG | |
| 30.01.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | ABB Sector Perform | RBC Capital Markets | |
| 29.01.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 29.01.25 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 29.01.25 | Swiss Re Buy | UBS AG | |
| 28.01.25 | ABB Underperform | Bernstein Research | |
| 28.01.25 | Givaudan Neutral | UBS AG | |
| 28.01.25 | Swiss Re Equal Weight | Barclays Capital | |
| 28.01.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 28.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 27.01.25 | Roche Neutral | UBS AG | |
| 27.01.25 | Novartis Buy | UBS AG | |
| 27.01.25 | Givaudan Add | Baader Bank |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.